Covetrus, Inc.
Covetrus, Inc. CVET Peers
See (CVET) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CVET | $20.99 | N/A | N/A | -69.97 | -$0.30 | N/A |
| MCK | $682.26 | -0.80% | 85.36B | 26.53 | $25.72 | +0.40% |
| COR | $279.16 | +0.06% | 54.11B | 32.27 | $8.65 | +0.58% |
| ABC | $179.98 | -0.23% | 36.15B | 21.92 | $8.21 | N/A |
| CAH | $148.36 | +0.07% | 35.41B | 23.22 | $6.39 | +1.36% |
| HSIC | $70.08 | -0.65% | 8.53B | 21.83 | $3.21 | N/A |
| PBH | $85.42 | -1.79% | 4.22B | 19.91 | $4.29 | N/A |
| PDCO | $31.33 | -0.90% | 2.77B | 20.48 | $1.53 | +1.66% |
| GRDN | $24.08 | -2.27% | 1.53B | -13.60 | -$1.77 | N/A |
| OMI | $7.00 | -3.18% | 536.30M | -1.47 | -$4.76 | N/A |
Stock Comparison
CVET vs MCK Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, MCK has a market cap of 85.36B. Regarding current trading prices, CVET is priced at $20.99, while MCK trades at $682.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas MCK's P/E ratio is 26.53. In terms of profitability, CVET's ROE is -0.06%, compared to MCK's ROE of -1.33%. Regarding short-term risk, CVET is less volatile compared to MCK. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs COR Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, COR has a market cap of 54.11B. Regarding current trading prices, CVET is priced at $20.99, while COR trades at $279.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas COR's P/E ratio is 32.27. In terms of profitability, CVET's ROE is -0.06%, compared to COR's ROE of +2.41%. Regarding short-term risk, CVET is less volatile compared to COR. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs ABC Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, ABC has a market cap of 36.15B. Regarding current trading prices, CVET is priced at $20.99, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas ABC's P/E ratio is 21.92. In terms of profitability, CVET's ROE is -0.06%, compared to ABC's ROE of +1.72%. Regarding short-term risk, CVET is less volatile compared to ABC. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs CAH Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, CAH has a market cap of 35.41B. Regarding current trading prices, CVET is priced at $20.99, while CAH trades at $148.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas CAH's P/E ratio is 23.22. In terms of profitability, CVET's ROE is -0.06%, compared to CAH's ROE of -0.50%. Regarding short-term risk, CVET is less volatile compared to CAH. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs HSIC Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, HSIC has a market cap of 8.53B. Regarding current trading prices, CVET is priced at $20.99, while HSIC trades at $70.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas HSIC's P/E ratio is 21.83. In terms of profitability, CVET's ROE is -0.06%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, CVET is less volatile compared to HSIC. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs PBH Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, PBH has a market cap of 4.22B. Regarding current trading prices, CVET is priced at $20.99, while PBH trades at $85.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas PBH's P/E ratio is 19.91. In terms of profitability, CVET's ROE is -0.06%, compared to PBH's ROE of +0.12%. Regarding short-term risk, CVET is less volatile compared to PBH. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs PDCO Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, PDCO has a market cap of 2.77B. Regarding current trading prices, CVET is priced at $20.99, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas PDCO's P/E ratio is 20.48. In terms of profitability, CVET's ROE is -0.06%, compared to PDCO's ROE of +0.14%. Regarding short-term risk, CVET is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for CVET.
CVET vs GRDN Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, GRDN has a market cap of 1.53B. Regarding current trading prices, CVET is priced at $20.99, while GRDN trades at $24.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas GRDN's P/E ratio is -13.60. In terms of profitability, CVET's ROE is -0.06%, compared to GRDN's ROE of -0.74%. Regarding short-term risk, CVET is less volatile compared to GRDN. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs OMI Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, OMI has a market cap of 536.30M. Regarding current trading prices, CVET is priced at $20.99, while OMI trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas OMI's P/E ratio is -1.47. In terms of profitability, CVET's ROE is -0.06%, compared to OMI's ROE of -0.51%. Regarding short-term risk, CVET is less volatile compared to OMI. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs WGRX Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, WGRX has a market cap of 92.98M. Regarding current trading prices, CVET is priced at $20.99, while WGRX trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas WGRX's P/E ratio is -11.93. In terms of profitability, CVET's ROE is -0.06%, compared to WGRX's ROE of -1.74%. Regarding short-term risk, CVET is less volatile compared to WGRX. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs ZYXI Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, ZYXI has a market cap of 63.50M. Regarding current trading prices, CVET is priced at $20.99, while ZYXI trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas ZYXI's P/E ratio is -8.75. In terms of profitability, CVET's ROE is -0.06%, compared to ZYXI's ROE of -0.24%. Regarding short-term risk, CVET is less volatile compared to ZYXI. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs HX Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, HX has a market cap of 53.37M. Regarding current trading prices, CVET is priced at $20.99, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas HX's P/E ratio is -1.84. In terms of profitability, CVET's ROE is -0.06%, compared to HX's ROE of -0.04%. Regarding short-term risk, CVET is less volatile compared to HX. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs GEG Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, GEG has a market cap of 53.09M. Regarding current trading prices, CVET is priced at $20.99, while GEG trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas GEG's P/E ratio is -38.00. In terms of profitability, CVET's ROE is -0.06%, compared to GEG's ROE of -0.02%. Regarding short-term risk, CVET is less volatile compared to GEG. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.
CVET vs RDGT Comparison
CVET plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVET stands at N/A. In comparison, RDGT has a market cap of 6.50M. Regarding current trading prices, CVET is priced at $20.99, while RDGT trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVET currently has a P/E ratio of -69.97, whereas RDGT's P/E ratio is -0.34. In terms of profitability, CVET's ROE is -0.06%, compared to RDGT's ROE of N/A. Regarding short-term risk, CVET is less volatile compared to RDGT. This indicates potentially lower risk in terms of short-term price fluctuations for CVET.